Effect of Shugan Hezhong Decoction in treatment of patients with diarrhea-predominant irritable bowel syndrome differentiated as liver depression and spleen deficiency syndrome

WANG Kejian; YANG Qin

doi:10.7619/jcmp.20213488

Journal of Clinical Medicine in Practice > 2021 > 25(23): 58-61, 68. > DOI: 10.7619/jcmp.20213488

WANG Kejian, YANG Qin. Effect of Shugan Hezhong Decoction in treatment of patients with diarrhea-predominant irritable bowel syndrome differentiated as liver depression and spleen deficiency syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(23): 58-61, 68. DOI: 10.7619/jcmp.20213488

Citation:

PDF (747 KB)

Effect of Shugan Hezhong Decoction in treatment of patients with diarrhea-predominant irritable bowel syndrome differentiated as liver depression and spleen deficiency syndrome

WANG Kejian,
YANG Qin^,

Nanjing Hospital of Traditional Chinese Medicine Affiliated to Nanjing Universityof Traditional Chinese Medicine, Nanjing, Jiangsu, 210001

More Information

Received Date: August 29, 2021
Available Online: December 05, 2021
Published Date: December 14, 2021

Graphical Abstract

Abstract

Abstract

Objective To observe the clinical effect of Shugan Hezhong Decoction in the treatment of patients with diarrhea-predominant irritable bowel syndrome (IBS-D) differentiated as liver depression and spleen deficiency syndrome.
Methods Totally 64 patients who met the diagnostic criteria of IBS-D differentiated as liver depression and spleen deficiency syndrome in Nanjing City Hospital of Traditional Chinese Medicine from March 2020 to March 2021 were selected and randomly divided into treatment group (treated with Shugan Hezhong Decoction) and control group (treated with live combined bacillus subtilis and enterococcus faecium enteric-coated capsules), with 32 cases in each group. After 4 weeks of treatment, the clinical symptom score and curative effect were evaluated in both groups.
Results After treatment, the main symptom score, secondary symptom score and total symptom score in both groups were significantly lower than those before treatment, and the main symptom score and total symptom score of the treatment group were significantly lower than those of the control group (P < 0.05). After treatment, the single symptom scores in both groups reduced significantly, and the single symptom scores of abdominal pain, stool shapes and properties, irritability, chest tightness and sigh and abdominal distension in the treatment group were significantly lower than those in the control group (P < 0.05). After treatment, the total effective rate in the treatment group was 93.75%, which was significantly higher than 68.75% in the control group (P < 0.05).
Conclusion Shugan Hezhong Decoction can effectively alleviate the gastrointestinal symptoms of patients with IBS-D differentiated as liver depression and spleen deficiency syndrome, enhance the treatment effect and improve the qualities of life of patients.

FullText(HTML)

References (27)

References

[1]	RAJILIC-STOJANOVIC M, JONKERS D M, SALONEN A, et al. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena[J]. Am J Gastroenterol, 2015, 110(2): 278-287. doi: 10.1038/ajg.2014.427
[2]	陈懿榕, 林柳兵, 李勇. 腹泻型肠易激综合征中西医研究进展探微[J]. 现代中西医结合杂志, 2019, 28(22): 2496-2500. doi: 10.3969/j.issn.1008-8849.2019.22.027
[3]	李军祥, 陈誩, 唐旭东, 等. 肠易激综合征中西医结合诊疗共识意见(2017年)[J]. 中国中西医结合消化杂志, 2018, 26(3): 227-233.
[4]	张声生, 魏玮, 杨俭勤. 肠易激综合征中医诊疗专家共识意见(2017)[J]. 中医杂志, 2017, 58(18): 1614-1620.
[5]	郑筱萸. 中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002: 11-15.
[6]	林三仁. 消化内科学高级教程[M]. 北京: 人民军医出版社, 2009: 33-41.
[7]	王子恺, 杨云生. 感染后肠易激综合征[J]. 胃肠病学和肝病学杂志, 2012, 21(10): 966-970.
[8]	李宁宁, 方秀才. 脑-肠轴在肠易激综合征发病中的作用[J]. 胃肠病学和肝病学杂志, 2013, 22(2): 163-166.
[9]	宁丽琴, 叶柏. 肠易激综合征研究进展[J]. 现代医学, 2008, 36(6): 449-452.
[10]	张磊. EphrinB2/ephB2调节ENS突触可塑性参与IBS内脏高敏感的机制研究[D]. 武汉: 华中科技大学, 2017.
[11]	SU J, TANAKA Y, MURATSUBAKI T, et al. Injection of corticotropin-releasing hormone into the amygdala aggravates visceral nociception and induces noradrenaline release in rats[J]. Neurogastroenterol Motil, 2015, 27(1): 30-39. doi: 10.1111/nmo.12462
[12]	贺延新, 刘琳琳, 王东明. 肠易激综合征与精神心理因素相关性的分析及研究[J]. 中国继续医学教育, 2017, 9(3): 84-86. doi: 10.3969/j.issn.1674-9308.2017.03.047
[13]	FACHI J L, FELIPE J S, PRAL L P, et al. Butyrate protects mice from Clostridium difficile-induced colitis through an HIF-1-dependent mechanism[J]. Cell Rep, 2019, 27(3): 750-761, e7. doi: 10.1016/j.celrep.2019.03.054
[14]	AKBAR A, YIANGOU Y, FACER P, et al. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain[J]. Gut, 2008, 57(7): 923-929. doi: 10.1136/gut.2007.138982
[15]	HAN W, WANG Z, LU X, et al. Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome[J]. Neurogastroenterol Motil, 2012, 24(2): 113-9, e82. doi: 10.1111/j.1365-2982.2011.01841.x
[16]	FOND G, LOUNDOU A, HAMDANI N, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis[J]. Eur Arch Psychiatry Clin Neurosci, 2014, 264(8): 651-660. doi: 10.1007/s00406-014-0502-z
[17]	JANSSENS K A, ZIJLEMA W L, JOUSTRA M L, et al. Mood and anxiety disorders in chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome: results from the LifeLines cohort study[J]. Psychosom Med, 2015, 77(4): 449-457. doi: 10.1097/PSY.0000000000000161
[18]	KOVÁCS Z, KOVÁCS F. Depressive and anxiety symptoms, coping strategies in patients with irritable bowel syndrome and inflammatory bowel disease[J]. Psychiatr Hung, 2007, 22(3): 212-221.
[19]	吴寒, 张振玉. 肠易激综合征东西方指南对比解读[J]. 胃肠病学和肝病学杂志, 2019, 28(9): 961-967. doi: 10.3969/j.issn.1006-5709.2019.09.001
[20]	(明)张介宾, 孙玉信, 朱平生主校. 景岳全书[M]. 上海: 第二军医大学出版社, 2006: 1.
[21]	黄翌, 赵长鹰. 肠易激综合征从情志论治探讨[J]. 山东中医杂志, 2004, 23(10): 579-581. doi: 10.3969/j.issn.0257-358X.2004.10.001
[22]	李聪. 痛泻要方对内脏高敏性肠易激综合征大鼠模型作用及机制[J]. 创伤与急危重病医学, 2019, 7(2): 109-111, 117.
[23]	孙羽中, 潘伟娟, 陈富丽, 等. 痛泻要方对肠易激综合征肝郁脾虚证大鼠中枢神经系统SERT的影响[J]. 中华中医药学刊, 2019, 37(6): 1408-1411.
[24]	高耀, 李肖, 周玉枝, 等. 代谢组学在逍遥散抗抑郁药理研究中的应用[J]. 中草药, 2019, 50(14): 3453-3460. doi: 10.7501/j.issn.0253-2670.2019.14.028
[25]	王海燕, 邓素萍, 陈奕霞. 四逆散合痛泻要方加味对腹泻型肠易激综合征患者血清IL-1β及IL-8水平的影响[J]. 中国中医药科技, 2015, 22(5): 487-488.
[26]	岳竹君, 李冬华, 白霞. 肠易激综合征模型大鼠不同脑区核团c-fos的蛋白表达[J]. 时珍国医国药, 2012, 23(4): 857-858. doi: 10.3969/j.issn.1008-0805.2012.04.030
[27]	周晓凤, 王晓妍, 曹志群. 基于脑-肠轴探析肠易激综合征发病机制[J]. 山东中医药大学学报, 2021, 45(1): 68-71.

[1]	ZHANG Zhuan, YU Yanlong, LI Hu, YUAN Bo, WANG Ying, YU Leyang, YAN Shiting. Effects of stellate ganglion block on postoperative cognitive dysfunction in elderly patients undergoing radical resection of gastrointestinal malignancy[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 107-111, 116. DOI: 10.7619/jcmp.20222735
[2]	YA Mingqin, DING Yonghe, ZHAO Xiangyu. Influence of nursing intervention on gastrointestinal function in patients with severe pancreatitis[J]. Journal of Clinical Medicine in Practice, 2018, (6): 40-43. DOI: 10.7619/jcmp.201806012
[3]	WANG Qian, SHEN Lijuan, GUAN Yunyan. Effect of immune-type enteral nutrition support on immune function of severe patients in ICU[J]. Journal of Clinical Medicine in Practice, 2017, (15): 71-73,77. DOI: 10.7619/jcmp.201715019
[4]	LI Shaoxing. Effect of different surgical treatment on immune function of patients with benign ovarian tumor[J]. Journal of Clinical Medicine in Practice, 2017, (5): 93-96. DOI: 10.7619/jcmp.201705026
[5]	ZHOU Yiyang, LI Shufang. Clinical efficacy of ginseng polysaccharides combined with chemotherapy in treatment of patients with moderate and advanced gastrointestinal cancer and its influence on immunological functional indexes[J]. Journal of Clinical Medicine in Practice, 2016, (23): 36-39. DOI: 10.7619/jcmp.201623011
[6]	DUAN Peifang, YANG Ruixian. Effect of preoperative nursing intervention on recovery of gastrointestinal function after abdominal surgery in the elderly with general anesthesia[J]. Journal of Clinical Medicine in Practice, 2016, (18): 108-110. DOI: 10.7619/jcmp.201618035
[7]	LI Xiuling. Effect of laparoscopic hysterectomy on ovarian function and immune function[J]. Journal of Clinical Medicine in Practice, 2016, (7): 93-95,108. DOI: 10.7619/jcmp.201607027
[8]	SONG Min, LI Jia, LIU Hongyan, LI Xiaomin, BI Quiping, HAN Tao. Influence of postoperative chemotherapy combined with huangqi granule on quality of life and immune function in patients with medium and advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2015, (16): 73-75. DOI: 10.7619/jcmp.201516023
[9]	LI Jingzhang, NI Bingqiang, JIANG Zhixiong, CHEN Rixin, ZHANG Zhihong, QIN Jianing, ZHU Zhou. Influence of parenteral nutrition supportive therapy on the nutritional status and immune function in patients with advanced gastrointestinal tumor in peri-chemotherapy period[J]. Journal of Clinical Medicine in Practice, 2014, (5): 20-23. DOI: 10.7619/jcmp.201405007
[10]	LI Shuan-jun, LIU Xin. Effect of perioperative enteral immunonutrition on postoperative immune function in patients with gastrointestinal cancer[J]. Journal of Clinical Medicine in Practice, 2012, (17): 46-48.

Cited By

Cited by

Periodical cited type(14)

1.	乔龙虎，贺莉，王超. 多层螺旋CT血管造影对颅内脑动脉瘤的诊断价值研究. 中国CT和MRI杂志. 2024(04): 26-27 .
2.	邰永星，谢军，郭婷婷，李海群. 多层螺旋CT血管造影对急性主动脉综合征的诊断和影像学特征. 中国医学装备. 2024(06): 40-44 .
3.	吴静萍，孟晓，卫勃，崔芳，孟庆林，张帆. 基于头颈CTA评估餐巾环征斑块与缺血性脑卒中的相关性研究. 临床放射学杂志. 2024(07): 1089-1094 .
4.	金兆维，王亚利，张丹丹，胡佳伟，曹宏伟. MSCTA在颈动脉血管支架植入术前后颈动脉狭窄程度评估中的应用. 中国CT和MRI杂志. 2024(07): 31-33 .
5.	杨金伟. 颅脑CT+CTA及颅脑MRI平扫在脑缺血性疾病中的应用价值. 影像研究与医学应用. 2024(17): 19-22 .
6.	陶丽. 彩色多普勒超声和CT血管造影对颈动脉狭窄患者颈动脉粥样硬化斑块的诊断价值. 中外医学研究. 2023(04): 72-75 .
7.	高红凤，王朝艳，高东艳. 头颈部CT血管成像技术评估颈部动脉粥样硬化的价值. 中国实用医刊. 2023(01): 77-80 .
8.	鲁强，杨瑞山，王可. CTA对脑梗塞性颈内动脉斑块性质的评价. 中国CT和MRI杂志. 2023(05): 18-20 .
9.	仇娟. 多层螺旋CT血管造影在糖尿病患者的下肢动脉粥样硬化检测中的应用价值. 影像研究与医学应用. 2023(11): 118-121 .
10.	潘昌庆. 头颈CTA对缺血性脑卒中患者颈动脉粥样硬化诊断的价值分析. 现代诊断与治疗. 2023(12): 1847-1849 .
11.	张强，高洁. CT血管造影与颈部超声在缺血性脑卒中颈动脉粥样硬化斑块及狭窄的检测效果. 中西医结合心血管病电子杂志. 2023(05): 88-90+57 .
12.	张益民，郑一兵. 心脏CT平扫与CT血管造影定量分析对心外膜脂肪体积的测定效果比较. 实用临床医药杂志. 2022(03): 21-24 . 本站查看
13.	孔建营，刘学财. 双源CT双能量血管成像在颈动脉斑块影像学特征评价中的应用价值. 世界复合医学. 2022(07): 53-56 .
14.	申太忠，姚志敏，李宝，谢灵争. 计算机断层扫描血管造影在颈动脉狭窄和颈动脉粥样硬化斑块形态评估中的应用价值. 血管与腔内血管外科杂志. 2022(09): 1067-1070 .

Other cited types(0)

Get Citation

PDF

XML

Article views (273) PDF downloads (13) Cited by(14)

Turn off MathJax

Article Contents

Abstract

References

Effect of Shugan Hezhong Decoction in treatment of patients with diarrhea-predominant irritable bowel syndrome differentiated as liver depression and spleen deficiency syndrome

Abstract

References

Related Articles

Cited by

Periodical cited type(14)

Other cited types(0)

Catalog

Effect of Shugan Hezhong Decoction in treatment of patients with diarrhea-predominant irritable bowel syndrome differentiated as liver depression and spleen deficiency syndrome

Abstract

References

Related Articles

Cited by

Periodical cited type(14)

Other cited types(0)

Catalog

Export File

Citation

Format

Content